Filtered By:
Condition: Depression
Drug: Enbrel

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 8 results found since Jan 2013.

Effect of Inflammation on the Process of Stroke Rehabilitation and Poststroke Depression
Conclusions Stroke comprises ischemic stroke and ICH. The immuno-inflammatory process is involved in neural plasticity following events such as a hemorrhage or ischemic stroke. After ischemia, astrocytes, microglia, and MDMs play important roles during rehabilitation with the modulation of cytokines or chemokines, such as TNF-α and IL-1. Moreover, MiRNAs are also important posttranscriptional regulators in these glial mitochondrial responses to cerebral ischemia. ICH involves processes similar and different to those seen in ischemia, including neuronal injury, astrocytic and microglial/macrophage activation, and n...
Source: Frontiers in Psychiatry - April 10, 2019 Category: Psychiatry Source Type: research

Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
Conclusions: Our data suggest that XPro1595 and etanercept improve functional outcome after focal cerebral ischemia by altering the peripheral immune response, changing blood and spleen cell populations and decreasing granulocyte infiltration into the brain. Blocking solTNF, using XPro1595, was just as efficient as blocking both solTNF and tmTNF using etanercept. Our findings may have implications for future treatments with anti-TNF drugs in TNF-dependent diseases.
Source: Journal of Neuroinflammation - December 12, 2014 Category: Neurology Authors: Bettina ClausenMatilda DegnNellie MartinYvonne CouchLeena KarimiMaria OrmhøjMaria-Louise MortensenHanne GredalChris GardinerIan SargentDavid SzymkowskiGéraldine PetitTomas DeierborgBente FinsenDaniel AnthonyKate Lambertsen Source Type: research

Rapid improvement in severe long COVID following perispinal etanercept
CONCLUSION: Perispinal etanercept is a promising treatment for the chronic neurologic dysfunction that may persist after resolution of acute COVID-19, including chronic cognitive dysfunction, fatigue, and depression. These results suggest that long COVID brain neuroinflammation is a potentially reversible pathology and viable treatment target. In view of the increasing unmet medical need, clinical trials of perispinal etanercept for long COVID are urgently necessary. The robust results of the present case suggest that perispinal etanercept clinical trials studying long COVID populations with severe fatigue, depression and ...
Source: Current Medical Research and Opinion - July 6, 2022 Category: Research Authors: Edward Tobinick Robert N Spengler Tracey A Ignatowski Manar Wassel Samantha Laborde Source Type: research